Ginkgo Bioworks Holdings, Inc. (DNA) Financials

DNA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 2.0 billion 773.7 million
2023-06-30 2.3 billion 788.4 million
2023-03-31 2.4 billion 809.6 million
2022-12-31 2.5 billion 803.0 million

DNA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -77.9 million 52.6 million
2023-06-30 -87.1 million 61.5 million
2023-03-31 -110.0 million 73.0 million
2022-12-31 -130.3 million 108.2 million

DNA Net Income

No data available :(

DNA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 1.0 billion - 403.7 million
2023-06-30 1.1 billion - 410.9 million
2023-03-31 1.2 billion - 404.1 million
2022-12-31 1.3 billion - 413.3 million

DNA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 2.0 billion
2023-06-30 1.9 billion
2023-03-31 1.9 billion
2022-12-31 1.9 billion

DNA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 4.4 million 156.7 million 82.0 million -
2023-06-30 13.5 million 144.3 million 102.3 million -
2023-03-31 19.4 million 162.6 million 111.4 million -
2022-12-31 25.6 million 181.2 million 121.4 million -

DNA Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 55.4 million 6.9 million
2023-06-30 80.6 million 18.1 million
2023-03-31 80.7 million 22.4 million
2022-12-31 98.3 million 30.2 million

DNA

Price: $0.93

52 week price:
0.78
2.55

Earnings Per Share: -0.46 USD

P/E Ratio: -3.68

Exchange: NYQ

Sector: Healthcare

Industry: Biotechnology

Volume: 21.0 million

Market Capitalization: 2.3 billion

Links: